News related to Plavix (Clopidogrel) and/or conditions it is approved for
FDA Announces New Warning On Plavix: Avoid Use With Prilosec/Prilosec OTC
Source: Health News from Medical News Today [2009.11.19]
Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17. New data suggest that when patients take both Prilosec and Plavix, Plavix's ability to block platelet aggregation (anti-clotting effect) may be reduced by about half.
New Anti-Clotting Drug Beats Plavix
Source: MedicineNet warfarin Specialty [2009.08.31]
Title: New Anti-Clotting Drug Beats Plavix
Category: Health News
Created: 8/30/2009 8:10:00 AM
Last Editorial Review: 8/31/2009
AHA: Low Bleeding Rates Observed in Dabigatran Dose-Ranging Trial (CME/CE)
Source: MedPage Today Cardiovascular [2009.11.19]
ORLANDO (MedPage Today) -- The oral anticoagulant dabigatran did not appear to markedly increase major bleeding rates among post-MI patients who were already being treated with aspirin and clopidogrel (Plavix), researchers said here.
AHA: FDA Drops Clopidogrel Bomb at AHA
Source: MedPage Today Gastroenterology [2009.11.17]
ORLANDO (MedPage Today) -- The FDA has issued a public health advisory warning patients and physicians that concommitant use of clopidogrel (Plavix) and omeprazole (Prilosec and Prilosec OTC) blunts the antiplatelet effect of clopidogrel, so the combination should be avoided.
Certain Reflux Drugs Tied to Higher Post-Angioplasty Death
Rate (HealthDay)
Source: Y! Health News Search RSS Feed [2009.11.16]
HealthDay - MONDAY, Nov. 16 (HealthDay News) -- People taking the acid
reflux drugs Prilosec or Protonix in combination with blood thinners such
as Plavix have a higher risk for death after angioplasty than people who
don't take the two popular antacids, a new study has found.
AHA: Prasugrel Incorporated into New STEMI Guidelines (CME/CE)
Source: MedPage Today Cardiovascular [2009.11.18]
ORLANDO (MedPage Today) -- A 60-milligram loading dose of prasugrel (Effient) is now a recommended alternative to clopidogrel for patients with ST-elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention, according to updated guidelines.
|
